Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe latest record history shows Revision: v3.7.0 as the current version, replacing the previous Revision: v3.6.6. This reflects a site update to the record history page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history shows a new platform revision entry: v3.6.6 superseding v3.6.5. This indicates a small software update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry, v3.6.5, was added to the study history. The previous revision, v3.6.4, was removed from the history.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions, updating the historical record to the latest version. The previous entry v3.6.3 was removed as part of this update.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded revision v3.6.3 to the Record History and removed revision v3.6.2. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page now includes an expanded footer with official site links and branding, and the record history section lists past versions and their submission dates.SummaryDifference34%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.